Coinbase
| CURRENT PRICE | PROBABILITY-WEIGHTED FAIR VALUE | FAIR VALUE RANGE |
|---|---|---|
| $146.26 | ~$185 | $95 – $260 |
| Jul 31, 2026 close (−10.6% on print) — confirm on live feed | House view: Constructive, high beta | Rev −14% QoQ; GAAP loss, adj. EBITDA +$208M |
July 2026 update: Coinbase reported Q2 2026 after the close on July 30, 2026. Figures below are verified against the company's SEC Form 8-K (Item 2.02) earnings release / Q2 deck[1]; analyst actions and estimate beats/misses are from Benzinga Pro[2].
House View: Constructive, high beta (July 2026). Still a leveraged bet on the crypto cycle — and Q2 was a soft-tape quarter that came in below the Street on both lines (a "double miss"): total revenue of $1.22B missed the ~$1.32B estimate and fell 14% QoQ (−19% YoY) as total crypto spot volumes dropped ~25% QoQ and volatility hit multi-year lows, while the adjusted loss of ~$(0.40)/share was wider than the ~$(0.11) consensus; transaction revenue was $599M (−21% QoQ). The company posted a GAAP net loss of $(359.5)M (−$1.36 diluted), but that was driven by $209M of mark-to-market losses on crypto held for investment — adjusted EBITDA stayed positive at $208M, the 14th consecutive positive quarter, and subscription & services revenue held at 48% of net revenue ($555M), a genuine buffer independent of trading. The franchise kept improving through the down-tape: an all-time-high 10.3% crypto trading-volume market share, record USDC balances ($20B avg held in Coinbase products), prediction-markets revenue >2x QoQ, and a fortress balance sheet ($8.6B cash, ~$10B available; $2B returned via buybacks with $2B left). The stock fell ~11% on the print to $146 and the Street trimmed hard (Goldman $198→$173, Citi $400→$235, Needham $220→$177), though consensus stays Buy at ~$267. Our base of ~$185 is constructive versus the tape but respects how violently earnings swing with volumes; the $95–$260 range brackets a crypto-winter downside (Barclays $95) against a cycle re-acceleration.
CURRENT SNAPSHOT
| Metric | Value | Notes / Source |
|---|---|---|
| Stock price | $146.26 | Jul 31, 2026 close, −10.6% on print [4] |
| Q2 2026 revenue | $1.22B (−14% QoQ, −19% YoY) | Soft spot volumes (−25% QoQ) [1] |
| Q2 2026 EPS / net income | −$1.36 GAAP / −$359.5M | Loss driven by $209M crypto MTM markdowns [1] |
| Adjusted EBITDA | +$208M | 14th straight positive quarter [1] |
| Transaction / S&S revenue | $599M / $555M | S&S = 48% of net revenue [1] |
| Crypto trading share | 10.3% (ATH) | Share gains in spot + derivatives [1] |
| Cash / balance sheet | $8.6B cash; ~$10B available | $2B returned via buybacks; $2B left [1] |
BULL / BASE / BEAR SCENARIOS
| Scenario (weight) | Assumptions | Fair Value |
|---|---|---|
| Bull (25%) | Crypto cycle re-accelerates; derivatives, prediction markets and USDC economics scale on the ATH 10.3% share base | $260 |
| Base (50%) | Volumes stabilize near current levels; S&S buffer (48% of net rev) and cost discipline hold adjusted profitability | $185 |
| Bear (25%) | Prolonged crypto winter, volumes keep sliding, regulatory/competitive pressure; multiple and EPS compress | $95 |
| Probability-weighted | Crypto cycle leverage; earnings swing hard with volumes, but the franchise and balance sheet are strengthening. | ~$185 |
Key Risks
- BTC volume cycle: Transaction revenue tied to crypto trading volumes; highly cyclical.
- Regulation: SEC scrutiny continues; staking, exchange, and custody all under review.
- Competition: Binance, Kraken, derivatives platforms compete; CME for institutional.
- Crypto cycle: If BTC enters multi-year drawdown, volumes structurally lower.
What Would Change Our View
- Upside: BTC to $100K+, volume recovery, Base L2 monetization disclosure.
- Downside: BTC under $60K, sustained low volumes, adverse SEC action.
Sources
[1] SEC Form 8-K (Item 2.02), Coinbase Q2 2026 earnings release / shareholder deck, filed Jul 30, 2026 — sec.gov/Archives/…/q226earningsdeck_sec.htm
[2] Benzinga Pro — Coinbase news feed & analyst actions (Q2 "double miss": rev $1.22B vs $1.316B est, adj. EPS $(0.40) vs $(0.11) est; post-print PT cuts: Goldman $173, Oppenheimer $193, Needham $177, Rosenblatt $200, BTIG $240, Piper $146, Barclays $95; HC Wainwright Buy $265) — pro.benzinga.com
[3] https://coindcx.com/blog/us-stock/coinbase-q1-2026-earnings-results/
[4] https://finance.yahoo.com/quote/COIN/
Disclaimer
This output is for informational and research-assistance purposes only. It does not constitute investment, legal, tax, accounting, or other professional advice, and it is not a recommendation to buy, sell, or hold any security. Verify material facts independently and consult qualified advisors before making decisions.